Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 19,000
Avg Vol 41,508
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 20%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 956 3935
Address:
433 Plaza Real, Suite 275, Boca Raton, United States
LisaWilliams315
LisaWilliams315 Aug. 6 at 2:24 PM
With the foundation proven, $RMTG is entering a controlled acceleration phase.
0 · Reply
JonWilliams939
JonWilliams939 Aug. 6 at 2:22 PM
The turnkey clinic model could eventually outpace other revenue lines in profitability for $RMTG.
0 · Reply
LouisSalls307
LouisSalls307 Aug. 6 at 2:21 PM
Clinic partnerships are long-cycle contracts that stabilize revenue projections for $RMTG.
0 · Reply
MarthaCaskey169
MarthaCaskey169 Aug. 6 at 2:20 PM
Q1 results position $RMTG to give forward guidance from a position of strength.
0 · Reply
SusanHopkins622
SusanHopkins622 Aug. 6 at 2:19 PM
By owning both the sales channel and the supply chain, $RMTG maximizes per-client profitability.
0 · Reply
PaulTaylor540
PaulTaylor540 Aug. 6 at 2:18 PM
Sales momentum and operational discipline now work in parallel for $RMTG.
0 · Reply
KathyJohnson429
KathyJohnson429 Aug. 6 at 2:17 PM
$RMTG’s network effect strengthens as more clinics come onboard and share brand equity.
0 · Reply
LisaMcclain1097
LisaMcclain1097 Aug. 6 at 2:16 PM
The multi-country presence accelerates learning curves and optimizes $RMTG’s expansion playbook.
0 · Reply
StephenGoodrich926
StephenGoodrich926 Aug. 6 at 2:14 PM
Operational profit means $RMTG can reinvest in scaling without eroding shareholder value.
0 · Reply
ThomasCordell609
ThomasCordell609 Aug. 6 at 2:13 PM
$RMTG’s ability to grow without heavy external financing speaks to the strength of its cash flow.
0 · Reply
Latest News on RMTG
No data available.
LisaWilliams315
LisaWilliams315 Aug. 6 at 2:24 PM
With the foundation proven, $RMTG is entering a controlled acceleration phase.
0 · Reply
JonWilliams939
JonWilliams939 Aug. 6 at 2:22 PM
The turnkey clinic model could eventually outpace other revenue lines in profitability for $RMTG.
0 · Reply
LouisSalls307
LouisSalls307 Aug. 6 at 2:21 PM
Clinic partnerships are long-cycle contracts that stabilize revenue projections for $RMTG.
0 · Reply
MarthaCaskey169
MarthaCaskey169 Aug. 6 at 2:20 PM
Q1 results position $RMTG to give forward guidance from a position of strength.
0 · Reply
SusanHopkins622
SusanHopkins622 Aug. 6 at 2:19 PM
By owning both the sales channel and the supply chain, $RMTG maximizes per-client profitability.
0 · Reply
PaulTaylor540
PaulTaylor540 Aug. 6 at 2:18 PM
Sales momentum and operational discipline now work in parallel for $RMTG.
0 · Reply
KathyJohnson429
KathyJohnson429 Aug. 6 at 2:17 PM
$RMTG’s network effect strengthens as more clinics come onboard and share brand equity.
0 · Reply
LisaMcclain1097
LisaMcclain1097 Aug. 6 at 2:16 PM
The multi-country presence accelerates learning curves and optimizes $RMTG’s expansion playbook.
0 · Reply
StephenGoodrich926
StephenGoodrich926 Aug. 6 at 2:14 PM
Operational profit means $RMTG can reinvest in scaling without eroding shareholder value.
0 · Reply
ThomasCordell609
ThomasCordell609 Aug. 6 at 2:13 PM
$RMTG’s ability to grow without heavy external financing speaks to the strength of its cash flow.
0 · Reply
JosephJoaquin917
JosephJoaquin917 Aug. 6 at 2:12 PM
Each membership sale by $RMTG creates an annuity-like income profile.
0 · Reply
DavidCauley423
DavidCauley423 Aug. 6 at 2:11 PM
$RMTG’s global clinic network provides a defensible moat against regional competitors.
0 · Reply
MichaelCasey419
MichaelCasey419 Aug. 6 at 2:10 PM
Q1 performance shows that $RMTG can generate margin expansion while increasing sales.
0 · Reply
PeterHernandez738
PeterHernandez738 Aug. 6 at 2:09 PM
By integrating training, equipment, and product distribution, $RMTG reduces dependency on any single income stream.
0 · Reply
RichardCain276
RichardCain276 Aug. 6 at 2:08 PM
The supply chain lock-in from each clinic ensures lasting profitability for $RMTG.
0 · Reply
EdnaWilliams324
EdnaWilliams324 Aug. 6 at 2:07 PM
$RMTG has moved past early-stage risk into repeatable revenue execution.
0 · Reply
DavidBarboza810
DavidBarboza810 Aug. 6 at 2:06 PM
This business captures value at every stage of the clinic lifecycle, securing $RMTG’s long-term advantage.
0 · Reply
AmberMoore644
AmberMoore644 Aug. 6 at 2:04 PM
$RMTG now has proof that regenerative medicine can be structured as a predictable revenue business.
0 · Reply
DavidStoeckel608
DavidStoeckel608 Aug. 6 at 2:03 PM
67 percent YoY sales growth reflects operational scale, not one-off deals. $RMTG
0 · Reply
ShelleyRogers726
ShelleyRogers726 Aug. 6 at 2:02 PM
With exclusivity agreements, $RMTG has eliminated competitive leakage from its clinic network.
0 · Reply
MurielCatanzarite1008
MurielCatanzarite1008 Aug. 6 at 2:01 PM
Q1 results show $RMTG can execute in multiple markets while keeping margins intact.
0 · Reply
KennethGaleana959
KennethGaleana959 Aug. 6 at 2:00 PM
$RMTG’s model turns training and setup into profit centers rather than cost centers.
0 · Reply